Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer - Healy, L A; Ryan, A M; Carroll, P; Ennis, D; Crowley, V; Boyle, T; Kennedy, M J; Connolly, E; Reynolds, J V (Clin Oncol, 2010)